Red blood cell transfusion and its alternatives in oncologic surgery—A critical evaluation

Critical Reviews in Oncology/Hematology

Volumn 134, Issue , 2019, Pages 1-9

  Fischer, Dania ^a   Neb, Holger ^a   Choorapoikayil, Suma ^a   Zacharowski, Kai ^a   Meybohm, Patrick ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Patient blood management in oncologic surgery; Transfusion associated immunomodulation

Indexed keywords

ERYTHROPOIETIN; IRON;

ANEMIA; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; SALVAGE THERAPY; SURGICAL PATIENT; BLOOD TRANSFUSION; EVALUATION STUDY; NEOPLASM; POSTOPERATIVE COMPLICATION; PROCEDURES;

ANEMIA; BLOOD TRANSFUSION; EVALUATION STUDIES AS TOPIC; HUMANS; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 85058172144     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2018.11.011     Document Type: Review

References (101)

1. Aapro, M., Osterwalder, B., Scherhag, A., Burger, H.U., Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events. Br. J. Cancer 101:12 (2009), 1961–1971.
2. Aapro, M., Jelkmann, W., Constantinescu, S.N., Leyland-Jones, B., Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br. J. Cancer 106:7 (2012), 1249–1258.
3. Acheson, A.G., Brookes, M.J., Spahn, D.R., Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann. Surg. 256:2 (2012), 235–244.
4. Acheson, D.T., Stein, M.B., Paulus, M.P., Geyer, M.A., Risbrough, V.B., The effect of pregabalin on sensorimotor gating in’ low’ gating humans and mice. Neuropharmacology 63:3 (2012), 480–485.
5. Almizraq, R.J., Seghatchian, J., Acker, J.P., Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing. Transfus. Apher. Sci. 55:3 (2016), 281–291.
6. Amato, A., Pescatori, M., Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst. Rev.(1), 2006 CD005033.
7. Atzil, S., Arad, M., Glasner, A., Abiri, N., Avraham, R., Greenfeld, K., Rosenne, E., Beilin, B., Ben-Eliyahu, S., Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 109:6 (2008), 989–997.
8. Avni, T., Bieber, A., Grossman, A., Green, H., Leibovici, L., Gafter-Gvili, A., The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin. Proc. 90:1 (2015), 12–23.
9. Baergen, R.N., Johnson, D., Moore, T., Benirschke, K., Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch. Pathol. Lab. Med. 121:5 (1997), 508–511.
10. Baratelli, F., Lee, J.M., Hazra, S., Lin, Y., Walser, T.C., Schaue, D., Pak, P.S., Elashoff, D., Reckamp, K., Zhang, L., et al. PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. Am. J. Transl. Res. 2:4 (2010), 356–367.
11. Bennett, C.L., Silver, S.M., Djulbegovic, B., Samaras, A.T., Blau, C.A., Gleason, K.J., Barnato, S.E., Elverman, K.M., Courtney, D.M., McKoy, J.M., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299:8 (2008), 914–924.
12. Bergamin, F.S., Almeida, J.P., Landoni, G., Galas, F., Fukushima, J.T., Fominskiy, E., Park, C.H.L., Osawa, E.A., Diz, M.P.E., Oliveira, G.Q., et al. Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit. Care Med. 45:5 (2017), 766–773.
13. Bordin, J.O., Heddle, N.M., Blajchman, M.A., Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:6 (1994), 1703–1721.
14. Brookes, M.J., Hughes, S., Turner, F.E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A.T., Hotchin, N., Anderson, G.J., et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55:10 (2006), 1449–1460.
15. Buchner, A., Grimm, T., Schneevoigt, B.S., Wittmann, G., Kretschmer, A., Jokisch, F., Grabbert, M., Apfelbeck, M., Schulz, G., Gratzke, C., et al. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage. Scand. J. Urol. 51:2 (2017), 130–136.
16. Cata, J.P., Wang, H., Gottumukkala, V., Reuben, J., Sessler, D.I., Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br. J. Anaesth. 110:5 (2013), 690–701.
17. Catlin, E.A., Roberts, J.D. Jr., Erana, R., Preffer, F.I., Ferry, J.A., Kelliher, A.S., Atkins, L., Weinstein, H.J., Transplacental transmission of natural-killer-cell lymphoma. N. Engl. J. Med. 341:2 (1999), 85–91.
18. Catling, S., Williams, S., Freites, O., Rees, M., Davies, C., Hopkins, L., Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 63:12 (2008), 1332–1338.
19. Cerhan, J.R., Engels, E.A., Cozen, W., Davis, S., Severson, R.K., Morton, L.M., Gridley, G., Hartge, P., Linet, M., Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int. J. Cancer 123:4 (2008), 888–894.
20. Chen, Y., Williams, V., Filippova, M., Filippov, V., Duerksen-Hughes, P., Viral carcinogenesis: factors inducing DNA damage and virus integration. Cancers 6:4 (2014), 2155–2186.
21. Chipollini, J.J., Tang, D.H., Patel, S.Y., Garcia-Getting, R.E., Gilbert, S.M., Pow-Sang, J.M., Sexton, W.J., Spiess, P.E., Poch, M.A., Perioperative transfusion of leukocyte-depleted blood products in contemporary radical cystectomy cohort does not adversely impact short-term survival. Urology 103 (2017), 142–148.
22. Chow, E.J., Holly, E.A., Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study. Am. J. Epidemiol. 155:8 (2002), 725–731.
23. Davis, M., Sofer, M., Gomez-Marin, O., Bruck, D., Soloway, M.S., The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?. BJU Int. 91:6 (2003), 474–476.
24. de Almeida, J.P., Vincent, J.L., Galas, F.R., de Almeida, E.P., Fukushima, J.T., Osawa, E.A., Bergamin, F., Park, C.L., Nakamura, R.E., Fonseca, S.M., et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 122:1 (2015), 29–38.
25. Debeljak, N., Solar, P., Sytkowski, A.J., Erythropoietin and cancer: the unintended consequences of anemia correction. Front. Immunol., 5, 2014, 563.
26. Docherty, A.B., O'Donnell, R., Brunskill, S., Trivella, M., Doree, C., Holst, L., Parker, M., Gregersen, M., Pinheiro de Almeida, J., Walsh, T.S., et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ, 352, 2016, i1351.
27. Edgren, G., Hjalgrim, H., Reilly, M., Tran, T.N., Rostgaard, K., Shanwell, A., Titlestad, K., Adami, J., Wikman, A., Jersild, C., et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 369:9574 (2007), 1724–1730.
28. Edwards, T.J., Noble, E.J., Durran, A., Mellor, N., Hosie, K.B., Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br. J. Surg. 96:10 (2009), 1122–1128.
29. Ejaz, A., Spolverato, G., Kim, Y., Margonis, G.A., Gupta, R., Amini, N., Frank, S.M., Pawlik, T.M., Impact of blood transfusions and transfusion practices on long-term outcome following hepatopancreaticobiliary surgery. J. Gastrointest. Surg. 19:5 (2015), 887–896.
30. Eschwege, P., Dumas, F., Blanchet, P., Le Maire, V., Benoit, G., Jardin, A., Lacour, B., Loric, S., Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346:8989 (1995), 1528–1530.
31. European Medicines Agency, Cross-Sectional Guidelines for Therapy With Blood Components and Plasma Derivatives. 2018 http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/Querschnittsleitlinie_Gesamtdokument-englisch_07032011.pdf.
32. Fischer, D., Zacharowski, K.D., Meybohm, P., Savoring every drop – vampire or mosquito?. Crit. Care, 18(3), 2014, 306.
33. Fischer, D., Bussow, J., Meybohm, P., Weber, C.F., Zacharowski, K., Urbschat, A., Muller, M.M., Jennewein, C., Microparticles from stored red blood cells enhance procoagulant and proinflammatory activity. Transfusion 57:11 (2017), 2701–2711.
34. Fischer-Fodor, E., Miklasova, N., Berindan-Neagoe, I., Saha, B., Iron, inflammation and invasion of cancer cells. Clujul Med. 88:3 (2015), 272–277.
35. Gafter-Gvili, A., Rozen-Zvi, B., Vidal, L., Leibovici, L., Vansteenkiste, J., Gafter, U., Shpilberg, O., Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia—systematic review and meta-analysis of randomised controlled trials. Acta Oncol. 52:1 (2013), 18–29.
36. Gartner, H.V., Seidl, C., Luckenbach, C., Schumm, G., Seifried, E., Ritter, H., Bultmann, B., Genetic analysis of a sarcoma accidentally transplanted from a patient to a surgeon. N. Engl. J. Med. 335:20 (1996), 1494–1496.
37. Gately, S., Li, W.W., Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin. Oncol. 31:2 Suppl 7 (2004), 2–11.
38. German Medical Association, Guideline on Non-Clinical and Clinical Development of Similar Biological Medicinal Products Containing Recombinant Erythropoietins (Revision). 2018 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/04/WC500089474.pdf.
39. Gross, I., Trentino, K.M., Andreescu, A., Pierson, R., Maietta, R.A., Farmer, S., Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. Oncologist 21:3 (2016), 327–332.
40. Hansen, E., Knuechel, R., Altmeppen, J., Taeger, K., Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 39:6 (1999), 608–615.
41. Heiss, M.M., Fasol-Merten, K., Allgayer, H., Strohlein, M.A., Tarabichi, A., Wallner, S., Eissner, H.I., Jauch, K.W., Schildberg, F.W., Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang. 73:4 (1997), 237–245.
42. Henke, M., Laszig, R., Rube, C., Schafer, U., Haase, K.D., Schilcher, B., Mose, S., Beer, K.T., Burger, U., Dougherty, C., et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362:9392 (2003), 1255–1260.
43. Hirani, R., Balogh, Z.J., Lott, N.J., Hsu, J.M., Irving, D.O., Leukodepleted blood components do not remove the potential for long-term transfusion-associated microchimerism in Australian major trauma patients. Chimerism 5:3-4 (2014), 86–93.
44. Hladik, W., Dollard, S.C., Mermin, J., Fowlkes, A.L., Downing, R., Amin, M.M., Banage, F., Nzaro, E., Kataaha, P., Dondero, T.J., et al. Transmission of human herpesvirus 8 by blood transfusion. N. Engl. J. Med. 355:13 (2006), 1331–1338.
45. Holst, L.B., Haase, N., Wetterslev, J., Wernerman, J., Guttormsen, A.B., Karlsson, S., Johansson, P.I., Aneman, A., Vang, M.L., Winding, R., et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N. Engl. J. Med. 16:4 (2014), 345–347.
46. Horne, M.K. 3rd, Cullinane, A.M., Merryman, P.K., Hoddeson, E.K., The effect of red blood cells on thrombin generation. Br. J. Haematol. 133:4 (2006), 403–408.
47. Horowitz, M., Neeman, E., Sharon, E., Ben-Eliyahu, S., Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat. Rev. Clin. Oncol. 12:4 (2015), 213–226.
48. Isbister, J.P., Shander, A., Spahn, D.R., Erhard, J., Farmer, S.L., Hofmann, A., Adverse blood transfusion outcomes: establishing causation. Transfus. Med. Rev. 25:2 (2011), 89–101.
49. Jacobi, K.E., Wanke, C., Jacobi, A., Weisbach, V., Hemmerling, T.M., Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. J. Clin. Anesth. 12:2 (2000), 94–99.
50. Karam, O., Tucci, M., Toledano, B.J., Robitaille, N., Cousineau, J., Thibault, L., Lacroix, J., Le Deist, F., Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion 49:11 (2009), 2326–2334.
51. Keding, V., Zacharowski, K., Bechstein, W.O., Meybohm, P., Schnitzbauer, A.A., Patient Blood Management improves outcome in oncologic surgery. World J. Surg. Oncol., 16(1), 2018, 159.
52. Keeler, B., Simpson, J., Ng, S., Tselepis, C., Iqbal, T., Brookes, M., Acheson, A., The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. Colorectal Dis. 16:10 (2014), 794–800.
53. Keeler, B.D., Simpson, J.A., Ng, O., Padmanabhan, H., Brookes, M.J., Acheson, A.G., Group IT, Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer. Br. J. Surg. 104:3 (2017), 214–221.
54. Kim, Y.T., Kim, S.W., Yoon, B.S., Cho, H.J., Nahm, E.J., Kim, S.H., Kim, J.H., Kim, J.W., Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. Gynecol. Oncol. 105:1 (2007), 199–204.
55. Kim, J.M., Kim, G.S., Joh, J.W., Suh, K.S., Park, J.B., Ko, J.S., Kwon, C.H., Yi, N.J., Gwak, M.S., Lee, K.W., et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl. Int. 26:1 (2013), 84–89.
56. Kozek-Langenecker, S.A., Ahmed, A.B., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., De Robertis, E., Faraoni, D., Filipescu, D.C., Fries, D., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur. J. Anaesthesiol. 34:6 (2017), 332–395.
57. Lee, T.H., Paglieroni, T., Ohto, H., Holland, P.V., Busch, M.P., Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 93:9 (1999), 3127–3139.
58. Lidder, P.G., Sanders, G., Whitehead, E., Douie, W.J., Mellor, N., Lewis, S.J., Hosie, K.B., Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery—a prospective, randomised, controlled trial. Ann. R. Coll. Surg. Engl. 89:4 (2007), 418–421.
59. Liu, L., Wang, Z., Jiang, S., Shao, B., Liu, J., Zhang, S., Zhou, Y., Zhou, Y., Zhang, Y., Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One, 8(5), 2013 e64261.
60. Ludwig, H., Van Belle, S., Barrett-Lee, P., Birgegard, G., Bokemeyer, C., Gascon, P., Kosmidis, P., Krzakowski, M., Nortier, J., Olmi, P., et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur. J. Cancer 40:15 (2004), 2293–2306.
61. Ludwig, H., Evstatiev, R., Kornek, G., Aapro, M., Bauernhofer, T., Buxhofer-Ausch, V., Fridrik, M., Geissler, D., Geissler, K., Gisslinger, H., et al. Iron metabolism and iron supplementation in cancer patients. Wien. Klin. Wochenschr. 127:23–24 (2015), 907–919.
62. Magee, C.C., Sayegh, M.H., Peptide mediated immunosuppression: new developments. Transplant. Proc. 30:5 (1998), 2131–2135.
63. Martin, D., Gutkind, J.S., Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 27:Suppl. 2 (2008), S31–S42.
64. Mavros, M.N., Xu, L., Maqsood, H., Gani, F., Ejaz, A., Spolverato, G., Al-Refaie, W.B., Frank, S.M., Pawlik, T.M., Perioperative blood transfusion and the prognosis of pancreatic cancer surgery: systematic review and meta-analysis. Ann. Surg. Oncol. 22:13 (2015), 4382–4391.
65. Meybohm, P., Herrmann, E., Steinbicker, A.U., Wittmann, M., Gruenewald, M., Fischer, D., Baumgarten, G., Renner, J., Van Aken, H.K., Weber, C.F., et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome: a prospective, multicenter cohort study with a noninferiority design. Ann. Surg. 264:2 (2016), 203–211.
66. Meybohm, P., Richards, T., Isbister, J., Hofmann, A., Shander, A., Goodnough, L.T., Munoz, M., Gombotz, H., Weber, C.F., Choorapoikayil, S., et al. Patient blood management bundles to facilitate implementation. Transfus. Med. Rev. 31:1 (2017), 62–71.
67. Mhaskar, R., Wao, H., Miladinovic, B., Kumar, A., Djulbegovic, B., The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Cochrane Database Syst. Rev., 2, 2016 CD009624.
68. Mincheff, M.S., Getsov, S.I., Meryman, H.T., Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model. Transplantation 60:8 (1995), 815–821.
69. Miyazono, F., Natsugoe, S., Takao, S., Tokuda, K., Kijima, F., Aridome, K., Hokita, S., Baba, M., Eizuru, Y., Aikou, T., Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann. Surg. 233:2 (2001), 189–194.
70. Murphy, G.J., Pike, K., Rogers, C.A., Wordsworth, S., Stokes, E.A., Angelini, G.D., Reeves, B.C., Investigators, T.I., Liberal or restrictive transfusion after cardiac surgery. N. Engl. J. Med. 372:11 (2015), 997–1008.
71. Opelz, G., Terasaki, P.I., Improvement of kidney-graft survival with increased numbers of blood transfusions. N. Engl. J. Med. 299:15 (1978), 799–803.
72. Ozment, C.P., Mamo, L.B., Campbell, M.L., Lokhnygina, Y., Ghio, A.J., Turi, J.L., Transfusion-related biologic effects and free hemoglobin, heme, and iron. Transfusion 53:4 (2013), 732–740.
73. Park, S., Jung, C.W., Kim, K., Kim, S.J., Kim, W.S., Jang, J.H., Iron deficient erythropoiesis might play key role in development of anemia in cancer patients. Oncotarget 6:40 (2015), 42803–42812.
74. Racila, E., Euhus, D., Weiss, A.J., Rao, C., McConnell, J., Terstappen, L.W., Uhr, J.W., Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. U. S. A. 95:8 (1998), 4589–4594.
75. Riedl, R., Engels, E.A., Warren, J.L., Berghold, A., Ricker, W., Pfeiffer, R.M., Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion 53:10 (2013), 2198–2206.
76. Rizzo, J.D., Brouwers, M., Hurley, P., Seidenfeld, J., Arcasoy, M.O., Spivak, J.L., Bennett, C.L., Bohlius, J., Evanchuk, D., Goode, M.J., et al. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116:20 (2010), 4045–4059.
77. Rohde, J.M., Dimcheff, D.E., Blumberg, N., Saint, S., Langa, K.M., Kuhn, L., Hickner, A., Rogers, M.A., Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:13 (2014), 1317–1326.
78. Saas, P., Angelot, F., Bardiaux, L., Seilles, E., Garnache-Ottou, F., Perruche, S., Phosphatidylserine-expressing cell by-products in transfusion: a pro-inflammatory or an anti-inflammatory effect?. Transfus. Clin. Biol. 19:3 (2012), 90–97.
79. Schiergens, T.S., Rentsch, M., Kasparek, M.S., Frenes, K., Jauch, K.W., Thasler, W.E., Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis. Colon Rectum 58:1 (2015), 74–82.
80. Schrijvers, D., De Samblanx, H., Roila, F., Group EGW, Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann. Oncol. 21:Suppl. 5 (2010), v244–v247.
81. Sim, V., Kao, L.S., Jacobson, J., Frangos, S., Brundage, S., Wilson, C.T., Simon, R., Glass, N.E., Pachter, H.L., Todd, S.R., Can old dogs learn new “transfusion requirements in critical care”: a survey of packed red blood cell transfusion practices among members of the American Association for the Surgery of Trauma. Am. J. Surg. 210:1 (2015), 45–51.
82. Soontrapa, K., Honda, T., Sakata, D., Yao, C., Hirata, T., Hori, S., Matsuoka, T., Kita, Y., Shimizu, T., Kabashima, K., et al. Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc. Natl. Acad. Sci. U. S. A. 108:16 (2011), 6668–6673.
83. Soubra, A., Zabell, J.R., Adejoro, O., Konety, B.R., Effect of perioperative blood transfusion on mortality for major urologic malignancies. Clin. Genitourin. Cancer 13:3 (2015), e173–e181.
84. Stoffel, J.T., Topjian, L., Libertino, J.A., Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int. 96:3 (2005), 313–315.
85. Sun, C., Wang, Y., Yao, H.S., Hu, Z.Q., Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int. J. Surg. 13 (2015), 102–110.
86. Sutton, J.M., Kooby, D.A., Wilson, G.C., Squires, M.H. 3rd, Hanseman, D.J., Maithel, S.K., Bentrem, D.J., Weber, S.M., Cho, C.S., Winslow, E.R., et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J. Gastrointest. Surg. 18:9 (2014), 1575–1587.
87. Tohme, S., Simmons, R.L., Tsung, A., Surgery for cancer: a trigger for metastases. Cancer Res. 77:7 (2017), 1548–1552.
88. Tonia, T., Mettler, A., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., Bohlius, J., Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst. Rev., 12, 2012 CD003407.
89. Food and Drug Administration (FDA), Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp). 2018 https://www.fda.gov/Drugs/DrugSafety/ucm109375.htm.
90. Vamvakas, E.C., Blajchman, M.A., Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 21:6 (2007), 327–348.
91. Villanueva, C., Colomo, A., Bosch, A., Concepcion, M., Hernandez-Gea, V., Aracil, C., Graupera, I., Poca, M., Alvarez-Urturi, C., Gordillo, J., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N. Engl. J. Med. 368:1 (2013), 11–21.
92. Wang, T., Luo, L., Huang, H., Yu, J., Pan, C., Cai, X., Hu, B., Yin, X., Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann. Thorac. Surg. 97:5 (2014), 1827–1837.
93. Waters, J.H., Yazer, M., Chen, Y.F., Kloke, J., Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 52:10 (2012), 2167–2173.
94. Weiss, G., Goodnough, L.T., Anemia of chronic disease. N. Engl. J. Med. 352:10 (2005), 1011–1023.
95. Whitnall, M., Howard, J., Ponka, P., Richardson, D.R., A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci. U. S. A. 103:40 (2006), 14901–14906.
96. Wilson, M.J., Dekker, J.W.T., Harlaar, J.J., Jeekel, J., Schipperus, M., Zwaginga, J.J., The role of preoperative iron deficiency in colorectal cancer patients: prevalence and treatment. Int. J. Colorectal Dis. 32:11 (2017), 1617–1624.
97. Yamaguchi, K., Takagi, Y., Aoki, S., Futamura, M., Saji, S., Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann. Surg. 232:1 (2000), 58–65.
98. Yang, T.O., Cairns, B.J., Reeves, G.K., Green, J., Beral, V., Million Women Study c, Cancer risk among 21st century blood transfusion recipients. Ann. Oncol. 28:2 (2017), 393–399.
99. Yu, J.L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J.I., Coomber, B.L., Mackman, N., Rak, J.W., Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:4 (2005), 1734–1741.
100. Zaw, A.S., Kantharajanna, S.B., Maharajan, K., Tan, B., Vellayappan, B., Kumar, N., Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery?. Transfusion 57:2 (2017), 440–450.
101. Zhang, Y., Dai, Y., Zheng, T., Ma, S., Risk factors of non-Hodgkin lymphoma. Expert Opin. Med. Diagn. 5:6 (2011), 539–550.